JP6651202B1 - A novel lactic acid bacterium belonging to Streptococcus salivarius and its use - Google Patents
A novel lactic acid bacterium belonging to Streptococcus salivarius and its use Download PDFInfo
- Publication number
- JP6651202B1 JP6651202B1 JP2018196111A JP2018196111A JP6651202B1 JP 6651202 B1 JP6651202 B1 JP 6651202B1 JP 2018196111 A JP2018196111 A JP 2018196111A JP 2018196111 A JP2018196111 A JP 2018196111A JP 6651202 B1 JP6651202 B1 JP 6651202B1
- Authority
- JP
- Japan
- Prior art keywords
- lactic acid
- acid bacterium
- comparative example
- bacteria
- acid bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 176
- 241000894006 Bacteria Species 0.000 title claims abstract description 103
- 239000004310 lactic acid Substances 0.000 title claims abstract description 88
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 88
- 241000194024 Streptococcus salivarius Species 0.000 title claims abstract description 19
- 235000013305 food Nutrition 0.000 claims abstract description 29
- 239000000463 material Substances 0.000 claims abstract description 11
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 235000021107 fermented food Nutrition 0.000 claims 1
- 235000013322 soy milk Nutrition 0.000 abstract description 36
- 238000000855 fermentation Methods 0.000 abstract description 10
- 230000004151 fermentation Effects 0.000 abstract description 10
- 230000001112 coagulating effect Effects 0.000 abstract description 2
- 238000010586 diagram Methods 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 44
- 239000000047 product Substances 0.000 description 17
- 239000002609 medium Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 241000186660 Lactobacillus Species 0.000 description 9
- 240000006024 Lactobacillus plantarum Species 0.000 description 8
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 8
- 241000194017 Streptococcus Species 0.000 description 8
- 229940072205 lactobacillus plantarum Drugs 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- -1 polypropylene Polymers 0.000 description 6
- 108020004465 16S ribosomal RNA Proteins 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 229940039696 lactobacillus Drugs 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000057717 Streptococcus lactis Species 0.000 description 3
- 235000014897 Streptococcus lactis Nutrition 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 235000012970 cakes Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000015271 coagulation Effects 0.000 description 3
- 238000005345 coagulation Methods 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 230000005251 gamma ray Effects 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000013618 yogurt Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000186612 Lactobacillus sakei Species 0.000 description 2
- 241000192132 Leuconostoc Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 235000013353 coffee beverage Nutrition 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 1
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- MIDXCONKKJTLDX-UHFFFAOYSA-N 3,5-dimethylcyclopentane-1,2-dione Chemical compound CC1CC(C)C(=O)C1=O MIDXCONKKJTLDX-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-DJHAAKORSA-N 6-O-alpha-D-glucopyranosyl-alpha-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@](O)(CO)O1 PVXPPJIGRGXGCY-DJHAAKORSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000167854 Bourreria succulenta Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 235000003392 Curcuma domestica Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000186840 Lactobacillus fermentum Species 0.000 description 1
- 241000186606 Lactobacillus gasseri Species 0.000 description 1
- 241001468191 Lactobacillus kefiri Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- 241000186684 Lactobacillus pentosus Species 0.000 description 1
- 241000186869 Lactobacillus salivarius Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000192130 Leuconostoc mesenteroides Species 0.000 description 1
- DUKURNFHYQXCJG-UHFFFAOYSA-N Lewis A pentasaccharide Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)OC1CO DUKURNFHYQXCJG-UHFFFAOYSA-N 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 240000008790 Musa x paradisiaca Species 0.000 description 1
- 235000018290 Musa x paradisiaca Nutrition 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 241000295644 Staphylococcaceae Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000002360 beta-cryptoxanthin Nutrition 0.000 description 1
- 239000011774 beta-cryptoxanthin Substances 0.000 description 1
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000013736 caramel Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000019693 cherries Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000003373 curcuma longa Nutrition 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021121 fermented vegetables Nutrition 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 238000004388 gamma ray sterilization Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 235000008446 instant noodles Nutrition 0.000 description 1
- 235000014109 instant soup Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 235000015141 kefir Nutrition 0.000 description 1
- 235000008960 ketchup Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 229940012969 lactobacillus fermentum Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 229950006780 n-acetylglucosamine Drugs 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000007104 trypticase soy yeast extract medium Substances 0.000 description 1
- 108010050327 trypticase-soy broth Proteins 0.000 description 1
- 235000013976 turmeric Nutrition 0.000 description 1
- 235000015192 vegetable juice Nutrition 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
【課題】豆乳に対して強い発酵力をもち、短時間で豆乳を凝固させるストレプトコッカス・サリバリウスの提供。【解決手段】5x107個の菌数あたり5mLの10%豆乳含有溶液を37℃で6時間以内に凝固させることができる、ストレプトコッカス・サリバリウスに属する乳酸菌、前記乳酸菌による食品素材の発酵により得られた発酵物、前記乳酸菌または発酵物を含有する飲食物、および、食品素材に前記乳酸菌を接種し発酵させることを特徴とする前記発酵物の製造方法。【選択図】なしAn object of the present invention is to provide Streptococcus salivarius which has a strong fermenting power for soy milk and solidifies soy milk in a short time. A lactic acid bacterium belonging to Streptococcus salivarius capable of coagulating 5 mL of a 10% soymilk-containing solution at 37 ° C. within 6 hours per 5 × 10 7 bacteria, and a fermentation obtained by fermenting a food material with the lactic acid bacterium. And a food or drink containing the lactic acid bacterium or fermented product, and a food material, wherein the lactic acid bacterium is inoculated and fermented. [Selection diagram] None
Description
本発明は、ストレプトコッカス・サリバリウスに属する、豆乳に対して強い発酵力をもつ新規乳酸菌、上記乳酸菌を含有する飲食物、乳酸菌により得られた発酵物、及び当該発酵物を含有させた飲食物、上記乳酸菌を用いた発酵物の製造方法に関するものである。 The present invention belongs to Streptococcus salivarius, a novel lactic acid bacterium having strong fermentative power against soy milk, food and drink containing the lactic acid bacterium, fermented product obtained by lactic acid bacterium, and food and drink containing the fermented product, The present invention relates to a method for producing a fermented product using lactic acid bacteria.
ヒトの腸内には100兆個以上の菌が存在し、その種類も1000種以上あると言われている。腸内環境の維持や改善効果をもつ菌種は、善玉菌とよばれる乳酸菌である。乳酸菌は腸内で乳酸を生産することによって大腸菌や病原菌の増殖を抑制するだけではなく、便通の改善、免疫力の上昇による感染防御、抗アレルギー作用などの生理的効果も示す。 It is said that there are more than 100 trillion bacteria in the human intestine and more than 1000 species. Bacteria that have the effect of maintaining and improving the intestinal environment are lactic acid bacteria called good bacteria. Lactic acid bacteria not only suppress the growth of Escherichia coli and pathogenic bacteria by producing lactic acid in the intestine, but also exhibit physiological effects such as improved bowel movements, protection against infection by increasing immunity, and antiallergic effects.
こうした効果を期待してプロバイオジェニックスといわれるこれらの有用な乳酸菌を体内にとりこんで、日々の健康を維持するため、さまざまな乳酸菌発酵物が開発されている。 With the expectation of such effects, various lactic acid bacteria fermented products have been developed to incorporate these useful lactic acid bacteria, called probiogenics, into the body and maintain daily health.
このような乳酸発酵物に使用されている乳酸菌は、乳原料の発酵に適した動物性乳酸菌で、具体的にはラクトコッカス・ラクティス、ラクトバチルス・ブルガリス、ラクトバチルス・アシドフィリス、ストレプトコッカス・サーモフィリスなどである。 The lactic acid bacteria used in such a lactic acid fermentation product are animal lactic acid bacteria suitable for fermentation of milk raw materials, and specifically, Lactococcus lactis, Lactobacillus vulgaris, Lactobacillus acidophilis, Streptococcus thermos. Such as Philis.
その一方、乳製品に対するアレルギーや乳製品によって消化不良を引き起こす人々が存在しており、そうした人々は乳酸菌を食品から効果的に摂取することが難しいという現状があり、乳製品以外を発酵させ効果的に乳酸菌を摂取することができる新しい乳酸菌株の開発が必要となっている。 On the other hand, there are people who have allergies to dairy products and indigestion due to dairy products, and it is difficult for such people to effectively ingest lactic acid bacteria from foods. There is a need to develop new lactic acid bacteria strains that can ingest lactic acid bacteria.
最近、植物成分を発酵させることが可能な植物性乳酸菌が注目されている。植物性乳酸菌は、植物成分を発酵させるのみならず、酸性領域で生存、増殖することができるため、生きて腸まで届き、直接腸内環境の維持や改善効果をもつといわれている。これまでに乳原料以外を原料として植物成分を発酵できる乳酸菌が単離されており、豆乳を発酵できる植物性乳酸菌としてラクトバチルス・プランタルムに属する乳酸菌が知られている。たとえばラクトバチルス・プランタルムHOKKAIDO株は、豆乳を発酵基質として発酵させると凝固して固形のヨーグルト状になり、このヨーグルトは、免疫機能を刺激し、ストレスマーカーを減少させる(非許文献1)。ストレプトコッカス・サリバリウスは口腔内に存在して、口臭の低減や虫歯や歯周病などに関係する悪玉菌の増殖を阻止することが分かっている。 Recently, plant lactic acid bacteria capable of fermenting plant components have attracted attention. It is said that plant lactic acid bacteria not only ferment plant components, but also survive and proliferate in an acidic region, reach the intestine alive, and have an effect of directly maintaining and improving the intestinal environment. So far, lactic acid bacteria capable of fermenting plant components using raw materials other than milk raw materials have been isolated, and lactic acid bacteria belonging to Lactobacillus plantarum are known as plant lactic acid bacteria capable of fermenting soy milk. For example, when Lactobacillus plantarum HOKKAIDO strain is fermented using soymilk as a fermentation substrate, it solidifies to a solid yogurt state, and this yogurt stimulates immune function and reduces stress markers (Non-Patent Document 1). Streptococcus salivarius has been found to be present in the oral cavity to reduce bad breath and prevent the growth of bad bacteria associated with caries and periodontal disease.
しかしながら豆乳に対して強い発酵力をもち、短時間で豆乳を凝固させるストレプトコッカス・サリバリウスは発見されていない。 However, Streptococcus salivarius which has a strong fermenting power for soy milk and coagulates soy milk in a short time has not been found.
本発明者らは、上記課題を解決するため鋭意検討した結果、サクラの花から単離したストレプトコッカス・サリバリウスに属する乳酸菌が、従来の乳酸菌と比較して素早く豆乳を発酵凝固させることが可能であることを見出し、本発明を完成させた。 The present inventors have conducted intensive studies to solve the above problems, and as a result, lactic acid bacteria belonging to Streptococcus salivarius isolated from cherry blossoms can ferment and coagulate soy milk more quickly than conventional lactic acid bacteria. The inventors have found that the present invention has been completed.
本発明は、
5 x 107個の菌数あたり5mLの10%豆乳含有溶液を37℃で6時間以内に凝固させることができる、乳酸菌
である。
The present invention
It is a lactic acid bacterium capable of coagulating a 10% soymilk-containing solution at a concentration of 5 mL per 5 × 10 7 bacteria at 37 ° C. within 6 hours.
また、本発明は、上記乳酸菌による食品素材の発酵により得られた発酵物である。 Further, the present invention is a fermented product obtained by fermenting a food material with the lactic acid bacterium.
さらに、本発明は、上記発酵物を含有する飲食物である。 Further, the present invention is a food or drink containing the above fermented product.
またさらに、本発明は、上記乳酸菌を含有する飲食物である。 Still further, the present invention is a food or drink containing the lactic acid bacterium.
また、本発明は、食品素材に、上記乳酸菌を接種し、発酵させることを特徴とする発酵物の製造方法である。 Further, the present invention is a method for producing a fermented product, wherein a food material is inoculated with the lactic acid bacterium and fermented.
本発明の乳酸菌は、さまざまな植物成分や豆乳を発酵させることができ、さまざまな発酵基質をベースとするプロバイオティクスに用いられる飲料などの飲食物を調整することができる。 The lactic acid bacterium of the present invention can ferment various plant components and soymilk, and can prepare food and drink such as beverages used for probiotics based on various fermentation substrates.
以下、本発明の実施形態について説明する。以下の実施形態は、例示であって、本発明の範囲は、以下の実施形態で示すものに限定されない。なお、同様な内容については繰り返しの煩雑をさけるために、摘示説明を省略する。 Hereinafter, embodiments of the present invention will be described. The following embodiments are exemplifications, and the scope of the present invention is not limited to those shown in the following embodiments. In addition, in order to avoid repetitive complications about the same content, the description is omitted.
定義
便宜上、本願で使用される特定の用語は、ここに集めている。別途規定されない限り、本願で使用される全ての技術用語及び科学用語は、本発明が属する技術分野の当業者が一般的に理解するのと同じ意味を有する。文脈で別途明記されない限り、単数形「a」、「an」及び「the」は複数の言及を含む。
Definitions For convenience, certain terms used in the present application are collected here. Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Unless otherwise stated in context, the singular forms “a”, “an”, and “the” include plural references.
本発明で示す数値範囲及びパラメーターは、近似値であるが、特定の実施例に示されている数値は可能な限り正確に記載している。しかしながら、いずれの数値も本質的に、それぞれの試験測定値に見られる標準偏差から必然的に生じる特定の誤差を含んでいる。また、本明細書で使用する「約」という用語は、一般に、所与の値又は範囲の10%、5%、1%又は0.5%以内を意味する。或いは、用語「約」は、当業者が考慮する場合、許容可能な標準誤差内にあることを意味する。 The numerical ranges and parameters given in the present invention are approximations, but the numerical values given in specific examples are described as accurately as possible. However, any numerical value inherently contains certain errors necessarily resulting from the standard deviation found in each test measurement. Also, as used herein, the term "about" generally means within 10%, 5%, 1% or 0.5% of a given value or range. Alternatively, the term "about" means within an acceptable standard error, as considered by one skilled in the art.
乳酸菌
本実施形態の乳酸菌は、5 x 107個の菌数あたり5mLの10%豆乳含有溶液を37℃で6時間以内に凝固させることができる。条件「5 x 107個の菌数あたり5mLの10%豆乳含有溶液を37℃」とは、本実施形態の乳酸菌がこの条件でしか豆乳を凝固させることができないという意味ではなく、この条件下で6時間以内に当該豆乳を凝固させることができる能力を有することを意味する。従って、使用する乳酸菌の菌数、豆乳の濃度及び量並びに温度によって、豆乳含有溶液の凝固時間は異なる。
Lactic Acid Bacteria The lactic acid bacteria of the present embodiment can coagulate 5 mL of a 10% soymilk-containing solution at 37 ° C. within 6 hours per 5 × 10 7 cells. The condition “5 mL of a 10% soymilk-containing solution at 37 ° C. per 5 × 10 7 bacteria count” does not mean that the lactic acid bacterium of the present embodiment can coagulate soymilk only under these conditions. Means having the ability to coagulate the soymilk within 6 hours. Therefore, the coagulation time of the soymilk-containing solution varies depending on the number of lactic acid bacteria used, the concentration and amount of soymilk, and the temperature.
本実施形態において、10%豆乳含有溶液は、豆乳が10%(大豆固形分)含まれている水溶液(媒体:水)である。豆乳は、水で膨潤した大豆をすりつぶして煮つめた汁を濾した液体である。本実施形態において、「凝固」とは、ゲルとなった状態をいい、例えば、内径15mmのγ線滅菌済みポリプロピレン製遠沈管(ECK-15ML-R, アズワン社製)の底部における5mLの10%豆乳含有溶液が遠沈管の口を下方向に向けても当該豆乳が流れ出ない状態をいう。 In the present embodiment, the 10% soymilk-containing solution is an aqueous solution (medium: water) containing 10% (soybean solids) of soymilk. Soy milk is a liquid obtained by grinding soybeans swollen with water and boiled juice. In the present embodiment, “coagulation” refers to a gelled state, for example, 10% of 5 mL at the bottom of a γ-ray sterilized polypropylene centrifuge tube (ECK-15ML-R, manufactured by AS ONE Corporation) having an inner diameter of 15 mm. The state in which the soymilk does not flow out even if the soymilk-containing solution faces the mouth of the centrifuge tube downward.
本実施形態において、本実施形態の乳酸菌は、上記条件下において、上記豆乳を6時間以内に凝固させることができ、例えば、30分以上6時間以下の時間(例:30分以上、1時間以上、2時間以上又は3時間以上かつ4時間以下、5時間以下又は6時間以下の時間)で凝固させることができる。 In the present embodiment, the lactic acid bacterium of the present embodiment can coagulate the soybean milk within 6 hours under the above conditions, and for example, a time of 30 minutes or more and 6 hours or less (eg, 30 minutes or more, 1 hour or more) , 2 hours or more, or 3 hours or more and 4 hours or less, 5 hours or less, or 6 hours or less).
ある実施形態において、上記乳酸菌は、ストレプトコッカス属である。別の実施形態において、上記乳酸菌は、ストレプトコッカス・サリバリウスに属する。更に別の実施形態において、上記乳酸菌は、受託番号:NITE P-02785で寄託されている乳酸菌である。 In one embodiment, the lactic acid bacterium is of the genus Streptococcus. In another embodiment, the lactic acid bacterium belongs to Streptococcus salivarius. In yet another embodiment, the lactic acid bacterium is a lactic acid bacterium deposited under accession number: NITE P-02785.
上記乳酸菌による食品素材の発酵により得られた発酵物、その発酵物を含む飲食物及び上記乳酸菌を含む飲食物
本実施形態の発酵物は、上記乳酸菌による食品素材の発酵により得られる。また、本実施形態の飲食物は、その発酵物を含む。本実施形態において、食品素材は、上記乳酸菌により発酵できるものであればいかなる食品素材であってもよく、例えば、豆乳、果物及び野菜が挙げられる。上記乳酸菌を用いて発酵豆乳飲料を製造する場合には、まず使用する豆乳に適した条件で殺菌した豆乳に、上記乳酸菌を単独または他の微生物と同時に接種培養し、これを均質化処理することで発酵豆乳を得ることができる。果物又は野菜の場合も、豆乳と同様の方法により、発酵果汁又は発酵野菜を得ることができる。これら発酵物を未発酵野菜果汁や未発酵果汁、アルコール等と混合し、さらに各種栄養素、ビタミン、フレーバー等を添加して最終製品とすることも可能である。これらは、上記乳酸菌を生菌の状態で含有するので好ましい。
Fermented product obtained by fermentation of food material by lactic acid bacteria, food and drink containing the fermented product, and food and beverage containing lactic acid bacteria The fermented product of the present embodiment is obtained by fermentation of food material by the lactic acid bacteria. The food and drink of the present embodiment includes the fermented product. In the present embodiment, the food material may be any food material as long as it can be fermented by the lactic acid bacterium, and examples include soy milk, fruits and vegetables. In the case of producing a fermented soymilk beverage using the lactic acid bacteria, first, soymilk sterilized under conditions suitable for the soymilk to be used is inoculated and cultured with the lactic acid bacteria alone or simultaneously with other microorganisms, and homogenized. To obtain fermented soymilk. In the case of fruits or vegetables, fermented fruit juice or fermented vegetables can be obtained by the same method as for soymilk. These fermented products can be mixed with unfermented vegetable juice, unfermented juice, alcohol, and the like, and further added with various nutrients, vitamins, flavors, and the like to obtain a final product. These are preferable because they contain the lactic acid bacteria in a viable state.
本実施形態の飲食物は、溶液、固形状、粉末等、経口摂取可能な形態であればよく、特に限定するものではない。具体例としては、飲料(乳酸飲料、果汁飲料、豆乳飲料、野菜飲料、茶飲料、炭酸飲料、栄養飲料、スポーツ飲料、コーヒー飲料、スープ、アルコール飲料等)、乳製品(ヨーグルト、チーズ、バター、アイスクリーム等)、小麦粉製品(パン、麺、ケーキミックス等)、菓子(チョコレート、クッキー、キャンディー、キャラメル、ゼリー、ガム、和菓子等)、油脂食品(ドレッシング、マヨネーズ、クリーム等)、調味料(ソース、トマトケチャップ、酢、風味調味料、つゆのもと等)、即席食品(即席麺、即席スープ、味噌汁、缶詰、レトルト食品等)、サプリメント(錠剤、シロップ、顆粒剤、カプセル剤、速崩剤等)が挙げられる。 The food and drink of the present embodiment may be any form that can be orally ingested, such as a solution, a solid, and a powder, and is not particularly limited. Specific examples include drinks (lactic acid drinks, fruit drinks, soy milk drinks, vegetable drinks, tea drinks, carbonated drinks, nutritional drinks, sports drinks, coffee drinks, soups, alcoholic drinks, etc.), dairy products (yogurt, cheese, butter, Ice cream, etc.), flour products (bread, noodles, cake mix, etc.), confectionery (chocolate, cookies, candy, caramel, jelly, gum, Japanese confectionery, etc.), oil and fat foods (dressing, mayonnaise, cream, etc.), seasonings (source) , Tomato ketchup, vinegar, flavor seasoning, soup base, etc., instant food (instant noodles, instant soup, miso soup, canned food, retort food, etc.), supplements (tablets, syrups, granules, capsules, quick disintegrants) Etc.).
本実施形態の乳酸菌は、従来のプロバイオジェニックスに用いられる乳酸菌と同様に各種の用途に利用し、これを摂取することにより整腸作用、抗菌作用等の生理効果を期待できる。 The lactic acid bacterium of the present embodiment is used for various uses similarly to the lactic acid bacterium used in the conventional probiogenics, and by ingesting the lactic acid bacterium, a physiological effect such as an intestinal regulating action and an antibacterial action can be expected.
本実施形態の乳酸菌をヒトや動物が摂取する場合、量に厳格な制限はないが、その好適な摂取量は生菌数として1回あたり106CFUから1014CFUが好ましい。また、本実施形態の乳酸菌は継続的に摂取することが好ましいが、これに限定されることはなく、例えば隔週、隔日のように摂取間隔を開けた場合や短い摂取期間でもよい。 When the lactic acid bacterium of the present embodiment is consumed by humans or animals, the amount is not strictly limited, but a suitable intake is preferably 10 6 CFU to 10 14 CFU per serving as the number of viable bacteria. In addition, it is preferable that the lactic acid bacteria of the present embodiment be continuously taken, but the present invention is not limited to this. For example, the lactic acid bacteria may be taken every other week, every other day, or may be taken for a short period.
上記飲食物および発酵物には、各種栄養素、各種ビタミン、各種ミネラル、甘味料、乳化剤などの安定剤、増粘剤、食物繊維、フレーバー等の任意成分を配合することができる、 In the food and drink and fermented products, various nutrients, various vitamins, various minerals, sweeteners, stabilizers such as emulsifiers, thickeners, dietary fiber, optional components such as flavors can be blended,
栄養素としては、DHA、EPA、アセチルグルコサミン、カテキン、ウコン、プロポリス、アガリスク,β-クリプトキサンチン、ケルセチン、アントシアニン等が挙げられる。各種ビタミンとしてはビタミンA、ビタミンB1、ビタミンB2、ビタミンB6、ビタミンB12、ビタミンC、ビタミンD、ビタミンE、葉酸、ニコチンアミド、ビオチン、ビタミンK等が挙げられる。各種ミネラルとしてはマグネシウム、カルシウム、亜鉛、マンガン、鉄、ナトリウム、カリウム等が挙げられる。甘味料としてはショ糖、グルコース、フルクトース、トレハロース、キシロース、ラクトース、パラチノース、果糖ブドウ糖液糖、麦芽糖、果糖、蜂蜜などの糖類、ソルビトール、キシリトール、エリスリトール、ラクチトール、パラチニット、アスパルテーム、スクラロース、ステビア、アセスルファムK等の高甘味度甘味料が挙げられる。酸味料としてはクエン酸、乳酸、酢酸、リンゴ酸、酒石酸、酪酸等があげられる。フレーバーとしてはオレンジ系、シトラス系、ベリー系、アップル系、ミント系、グレープ系、アプリコット系、シソ系、レモン系、グレープフルーツ系、ピーチ系、バナナ系、トロピカル系、ハーブ系、コーヒー系、お茶系等があげられる。 Nutrients include DHA, EPA, acetylglucosamine, catechin, turmeric, propolis, agarisk, β-cryptoxanthin, quercetin, anthocyanins and the like. Examples of various vitamins include vitamin A, vitamin B1, vitamin B2, vitamin B6, vitamin B12, vitamin C, vitamin D, vitamin E, folic acid, nicotinamide, biotin, vitamin K, and the like. Various minerals include magnesium, calcium, zinc, manganese, iron, sodium, potassium and the like. Sweeteners include sucrose, glucose, fructose, trehalose, xylose, lactose, palatinose, fructose-glucose liquid sugar, maltose, fructose, honey and other sugars, sorbitol, xylitol, erythritol, lactitol, palatinit, aspartame, sucralose, stevia, acesulfame. Sweeteners with a high degree of sweetness such as K. Acidulants include citric acid, lactic acid, acetic acid, malic acid, tartaric acid, butyric acid and the like. Flavors include orange, citrus, berry, apple, mint, grape, apricot, perilla, lemon, grapefruit, peach, banana, tropical, herbal, coffee, and tea. And the like.
また、本実施形態の発酵物又は飲食物の製造の際には、本実施形態の乳酸菌以外の菌を併用することもできる。このような菌類としては、例えばビフィドバクテリウム・ビフィダム、ビフィドバクテリウム・ラクティス、ビフィドバクテリウム・ロンガム等のビフィドバクテリウム属細菌、ラクトバチルス・カゼイ、ラクトバチルス・アシドフィルス、ラクトバチルス・ブレビス、ラクトバチルス・ケフィア、ラクトバチルス・パラカゼイ、ラクトバチルス・サリバリウス、ラクトバチルス・ガセリ、ラクトバチルス・ファーメンタム、ラクトバチルス・ブルガリカス、ラクトバチルス・デルブルキィ、ラクトバチルス・ペントサス、ラクトバチルス・プランタルム等のラクトバチルス属細菌、ストレプトコッカス・サーモフィリス、ストレプトコッカス・サリバリウス等のストレプトコッカス属細菌、ラクトコッカス・ラクティス・サブスピーシス・ラクティス、ラクトコッカス・ラクティス・サブスピーシス・クレモリス等のラクトコッカス属細菌、エンテロコッカス・フェカリス等のエンテロコッカス属細菌、サッカロマイセス・セルビシエ、キャンディダ・ケフィア等のサッカロマイセス属、キャンディダ属等に属する酵母があげられる。 In addition, when producing the fermented product or food or drink of the present embodiment, bacteria other than the lactic acid bacteria of the present embodiment can be used in combination. Examples of such fungi include Bifidobacterium genus bacteria such as Bifidobacterium bifidum, Bifidobacterium lactis, Bifidobacterium longum, Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus Brevis, Lactobacillus kefir, Lactobacillus paracasei, Lactobacillus salivarius, Lactobacillus gasseri, Lactobacillus fermentum, Lactobacillus bulgaricus, Lactobacillus delbruchy, Lactobacillus pentosus, Lactobacillus plantarum, etc. Streptococcus bacteria such as Lactobacillus bacteria, Streptococcus thermophilis, Streptococcus salivarius, Lactococcus lactis subsp. Practices, Lactococcus bacteria such as Lactococcus lactis, subsp. Cremoris, Enterococcus bacteria such as Enterococcus faecalis, Saccharomyces cerevisiae, Saccharomyces genus such as Candida, kefir, yeast belonging to the genus Candida, and the like.
以下、実施例をあげて本発明の内容を詳細に説明するが、本発明はこれらにより何ら制約されるものではない、 Hereinafter, the content of the present invention will be described in detail with reference to examples, but the present invention is not limited thereto.
実施例の乳酸菌の単離及び培養条件
ストレプトコッカス・サリバリウスに属する新規乳酸菌は、以下に示す酒粕濾過培地を用いて単離した。800mLの蒸留水に200gの酒粕を加え弱火にかけ、よく撹拌して沸騰させて溶かす。火から下ろして50℃くらいになるまで冷まし、キッチンペーパーで濾過し、Brixを5.0に調整して121℃で15分間オートクレーブし、酒粕濾過培地として使用した。ヤエザクラの花に付着した菌類を酒粕濾過培地に接触させ、30℃、24時間培養し、生育した菌を単離した。単離後、121℃、15分間オートクレーブしたLactobacilli MRS Broth(Difco社製)培地で30℃、24時間の条件において培養可能であった菌を以後の実験で用いた。かかる菌は、Lactobacilli MRS Broth(Difco社製)培地において円形で白色のコロニーを形成した。顕微鏡観察において、上記菌は、球菌で運動性はなく、芽胞は形成しなかった(不図示)。上記菌は、グラム染色試験において陽性を示し、カタラーゼ活性試験において活性を示さず、また、ガス発生が観察されなかった(不図示)。
Isolation and Culture Conditions of Lactic Acid Bacteria in Examples A novel lactic acid bacterium belonging to Streptococcus salivarius was isolated using the following sake cake filtration medium. Add 800 g of sake lees to 800 mL of distilled water, heat over low heat, stir well and dissolve by boiling. The mixture was removed from the heat, cooled to about 50 ° C., filtered with kitchen paper, adjusted to a Brix of 5.0, autoclaved at 121 ° C. for 15 minutes, and used as a sake cake filtration medium. Fungi adhering to the flowers of Yaezakura were brought into contact with a sake lees filtration medium, cultured at 30 ° C. for 24 hours, and the grown bacteria were isolated. After the isolation, bacteria that could be cultured in a Lactobacilli MRS Broth (manufactured by Difco) medium autoclaved at 121 ° C. for 15 minutes at 30 ° C. for 24 hours were used in subsequent experiments. Such bacteria formed circular white colonies in the Lactobacilli MRS Broth (manufactured by Difco) medium. Under microscopic observation, the bacterium was a staphylococci, had no motility, and did not form spores (not shown). The above bacterium showed a positive result in the Gram stain test, showed no activity in the catalase activity test, and did not observe gas generation (not shown).
16S rDNA塩基配列を用いた菌種同定
上記菌の菌種同定を16S rDNA塩基配列に基づいて以下の方法で行った。MRS培地を用いて30℃、24時間培養した培養用菌液を遠心分離した菌体ペレットから抽出したDNAを鋳型として、16S rDNA配列の全長をPCR法によって増幅し、増幅産物の塩基配列をDye Terminator法により決定した。その塩基配列を配列番号1に示す。得られた塩基配列をデータベースで検索して菌種を同定した。その結果、前記乳酸菌の16S rDNAの塩基配列はストレプトコッカス・サリバリウスおよびストレプトコッカス・サーモフィリスの16S rDNA塩基配列と99%同一であることが確認できたが、ストレプトコッカス・サリバリウスは、ストレプトコッカス・サーモフィリスと異なり、牛乳を発酵させることができないことから、上記菌は、ストレプトコッカス・サリバリウスに属する乳酸菌の新株と同定し、ストレプトコッカス・サリバリウス サクラ2と命名して(以後、実施例の乳酸菌)、2018年9月19日に日本国千葉県木更津市かずさ鎌足2-5-8に住所を有する独立行政法人製品評価技術基盤機構特許微生物寄託センターに寄託された。受託番号はNITE P-02785である。
Bacterial species identification using 16S rDNA nucleotide sequence The bacterial species of the above bacteria was identified by the following method based on the 16S rDNA nucleotide sequence. Using a DNA extracted from a cell pellet obtained by centrifuging a culture solution for culture cultured at 30 ° C. for 24 hours in an MRS medium as a template, the full length of the 16S rDNA sequence is amplified by PCR, and the nucleotide sequence of the amplified product is determined by Dye. It was determined by the Terminator method. The nucleotide sequence is shown in SEQ ID NO: 1. The obtained nucleotide sequence was searched in a database to identify the bacterial species. As a result, the 16S rDNA nucleotide sequence of the lactic acid bacterium was confirmed to be 99% identical to the 16S rDNA nucleotide sequence of Streptococcus salivarius and Streptococcus thermophilis, but Streptococcus salivarius differs from Streptococcus thermophilis, Since the milk could not be fermented, the bacterium was identified as a new strain of lactic acid bacterium belonging to Streptococcus salivarius and named as Streptococcus salivarius sakura 2 (hereinafter referred to as lactic acid bacterium in Examples) on September 19, 2018. Was deposited at the National Institute of Technology and Evaluation Patent Microorganisms Depositary Center, located at 2-5-8 Kazusa-Kamashita, Kisarazu-shi, Chiba, Japan. The accession number is NITE P-02785.
実施例の乳酸菌の糖資化性を表1に示す。 Table 1 shows the sugar assimilation properties of the lactic acid bacteria of the examples.
比較例の乳酸菌の培養条件
比較例の乳酸菌として、ラクトバチルス・プランタルム(比較例1)、ラクトバチルス・サケイ(比較例2)、リューコノストック・メセンテロイデス(比較例3)及びストレプトコッカス・サリバリウス(比較例4)、ストレプトコッカス・サーモフィリス(比較例5)を用いた。比較例1から3の乳酸菌は、121℃、15分間オートクレーブしたLactobacilli MRS Broth(Difco社製)培地を用いて30℃で24時間培養した。比較例4及び5の乳酸菌は、121℃、15分間オートクレーブしたNITE Biological Resource Center (NBRC)推奨のトリプシケースソイイーストイクストラクト培地を用いて37℃で24時間培養した。
Culture conditions of lactic acid bacteria of comparative example Lactobacillus plantarum (Comparative Example 1), Lactobacillus sakei (Comparative Example 2), Leuconostoc mesenteroides (Comparative Example 3) and Streptococcus salivarius (Comparative Example) as lactic acid bacteria of Comparative Example 4), Streptococcus thermophilis (Comparative Example 5) was used. The lactic acid bacteria of Comparative Examples 1 to 3 were cultured at 30 ° C. for 24 hours using a Lactobacilli MRS Broth (manufactured by Difco) medium autoclaved at 121 ° C. for 15 minutes. The lactic acid bacteria of Comparative Examples 4 and 5 were cultured at 37 ° C. for 24 hours using a trypticase soy yeast extract medium recommended by NITE Biological Resource Center (NBRC) autoclaved at 121 ° C. for 15 minutes.
豆乳発酵試験で使用する菌数
37℃で24時間培養した乳酸菌の培養液を滅菌した希釈液(0.1%酵母エキス溶液)に適宜希釈後、スパイラルシステムにてMRS寒天平板培地に塗布し、生菌数を測定した。また生菌数を表わす単位であるCFU/mlは培養プレートおいて1ml接種した時のコロニー形成能を示す。その間培養した乳酸菌は4℃に保存し、そこから豆乳発酵用に5x107個の乳酸菌を1回量として使用した。
Number of bacteria used in soymilk fermentation test The culture solution of lactic acid bacteria cultured at 37 ° C for 24 hours is appropriately diluted with a sterilized diluent (0.1% yeast extract solution), applied to an MRS agar plate medium by a spiral system, and subjected to live bacteria. The number was measured. CFU / ml, which is a unit indicating the number of viable cells, shows the ability to form colonies when 1 ml of the culture plate is inoculated. The lactic acid bacteria cultured during that time were stored at 4 ° C., from which 5 × 10 7 lactic acid bacteria were used as a single dose for fermenting soymilk.
実施例の乳酸菌と比較例の乳酸菌による豆乳発酵時間の比較
(1)菌株
比較例1の乳酸菌(対照群)としてNBRCのラクトバチルス・プランタルムに属する10株(3074株(比較例1-1)、14712株(比較例1-2)、101972株(比較例1-3)、15891株(比較例1-4)、3070株(比較例1-5)、12006株(比較例1-6)、14713株(比較例1-7)、101973株(比較例1-8)、101975株(比較例1-9)、109604株(比較例1-10))、ラクトバチルス・プランタルムに属する2株(ラクトバチルス・プランタルムHOKKAIDO(比較例1-11)、ラクトバチルス・プランタルム SN13T(比較例1-12))を使用した。
Comparison of soymilk fermentation time between lactic acid bacteria of Example and lactic acid bacteria of comparative example (1) Strains 10 strains (3074 strains (Comparative Example 1-1) belonging to Lactobacillus plantarum of NBRC as lactic acid bacteria of Comparative Example 1 (control group), 14712 strains (Comparative Example 1-2), 101972 strains (Comparative Example 1-3), 15891 strains (Comparative Example 1-4), 3070 strains (Comparative Example 1-5), 12006 strains (Comparative Example 1-6), 14713 strains (Comparative Example 1-7), 101973 strains (Comparative Example 1-8), 101975 strains (Comparative Example 1-9), 109604 strains (Comparative Example 1-10), two strains belonging to Lactobacillus plantarum ( Lactobacillus plantarum HOKKAIDO (Comparative Example 1-11) and Lactobacillus plantarum SN13T (Comparative Example 1-12) were used.
比較例2の乳酸菌(対照群)としてNBRCのラクトバチルス・サケイに属する3株(3541株(比較例2-1)、107130株(比較例2-2)、15893株(比較例2-3))を使用した。 As lactic acid bacteria of Comparative Example 2 (control group), three strains belonging to Lactobacillus sakei of NBRC (3541 strains (Comparative Example 2-1), 107130 strains (Comparative Example 2-2), and 15893 strains (Comparative Example 2-3) )It was used.
比較例3の乳酸菌(対照群)としてNBRCのリューコノストックに属する7株(100495株(比較例3-1)、3832株(比較例3-2)、12060株(比較例3-3)、3349株(比較例3-4)、100496株(比較例3-5)、102481株(比較例3-6)、102475株(比較例3-7))を使用した。 As lactic acid bacteria of Comparative Example 3 (control group), 7 strains (100495 strains (Comparative Example 3-1), 3832 strains (Comparative Example 3-2), 12060 strains (Comparative Example 3-3) belonging to NBRC Leuconostoc, 3349 strains (Comparative Example 3-4), 100496 strains (Comparative Example 3-5), 102481 strains (Comparative Example 3-6), and 102475 strains (Comparative Example 3-7) were used.
比較例4の乳酸菌(対照群)としてNBRCのストレプトコッカス・サリバリウスに属する1株(13956株(比較例4))を使用した。 As a lactic acid bacterium of Comparative Example 4 (control group), one strain belonging to Streptococcus salivarius of NBRC (13956 strain (Comparative Example 4)) was used.
比較例5の乳酸菌(対照群)としてNBRCのストレプトコッカス・サーモフィリスに属する2株(13957株(比較例5-1)、111149株(比較例5-2))を使用した。 As lactic acid bacteria of Comparative Example 5 (control group), two strains belonging to Streptococcus thermophilis of NBRC (13957 strains (Comparative Example 5-1) and 111149 strains (Comparative Example 5-2)) were used.
(2)種菌と培養
比較例1から3の乳酸菌は、121℃、15分間滅菌したLactobacilli MRS Broth(Difco社製)をγ線滅菌済みポリプロピレン製遠沈管(ECK-15ML-R, アズワン社製)に分注したものに接種して30℃で24時間定常状態になるまで培養した。比較例4から5の乳酸菌は121℃、15分間オートクレーブ滅菌したトリプシケースソイイクストラクト培地をγ線滅菌済みポリプロピレン製遠沈管(ECK-15ML-R, アズワン社製)に分注したものに接種して37℃で24時間定常状態になるまで培養した。実施例1の乳酸菌(ストレプトコッカス・サリバリウス サクラ2)は、121℃、15分間オートクレーブ滅菌したLactobacilli MRS Broth(Difco社製)培地を、γ線滅菌済みポリプロピレン製遠沈管(ECK-15ML-R, アズワン社製)に分注したものに接種して30℃、24時間、定常状態になるまで培養した。
(2) Inoculum and culture Lactobacillus MRS Broth (manufactured by Difco) sterilized at 121 ° C. for 15 minutes was subjected to γ-ray sterilization in a polypropylene centrifuge tube (ECK-15ML-R, manufactured by ASONE Corporation). Was inoculated and cultured at 30 ° C. for 24 hours until a steady state was reached. The lactic acid bacteria of Comparative Examples 4 to 5 were inoculated into a trypticase soybean extract medium which had been autoclaved at 121 ° C. for 15 minutes and dispensed into a γ-ray sterilized polypropylene centrifuge tube (ECK-15ML-R, manufactured by AS ONE). Then, the cells were cultured at 37 ° C. for 24 hours until a steady state was reached. The lactic acid bacterium (Streptococcus salivarius Sakura 2) of Example 1 was prepared by dissolving a Lactobacilli MRS Broth (manufactured by Difco) medium autoclaved at 121 ° C. for 15 minutes into a γ-ray-sterilized polypropylene centrifuge tube (ECK-15ML-R, Asone Corporation). Was inoculated and cultured at 30 ° C. for 24 hours until a steady state was reached.
(3)豆乳の発酵
市販の10%豆乳(スジャータ めいらく製)を90℃、30分間滅菌し、γ線滅菌済みポリプロピレン製遠沈管(ECK-15ML-R, アズワン社製)に5mlずつ分注し、そこに5 x 107個の各乳酸菌(実施例1及び比較例1から5の乳酸菌)をそれぞれ添加し、37℃に保温した。その後、時間経過をおって豆乳が発酵して凝固する凝固時間を検討した。一回の実験に各三本ずつ計五回の実験を行って、各15検体の結果を表2に示した。
(3) Fermentation of soy milk Commercially available 10% soy milk (manufactured by Sujata Meiraku) is sterilized at 90 ° C. for 30 minutes, and dispensed into a γ-ray sterilized polypropylene centrifuge tube (ECK-15ML-R, manufactured by AS ONE Corporation) in 5 ml portions. Then, 5 × 10 7 lactic acid bacteria (lactic acid bacteria of Example 1 and Comparative Examples 1 to 5) were respectively added thereto, and the mixture was kept at 37 ° C. Thereafter, the coagulation time during which the soymilk fermented and solidified over time was examined. A total of five experiments were performed, three for each experiment, and the results for each of the 15 specimens are shown in Table 2.
表2に示した通り、実施例1の乳酸菌は、比較例4の乳酸菌(従来のストレプトコッカス・サリバリウス)と比較して半分以下の時間で、最も発酵力の強い比較例3の乳酸菌(リューコノストック・メッセンテロイデス)と比較しても約半分の時間で豆乳を発酵凝固させることができることから豆乳に対して非常に強い発酵力を持つことが証明された。 As shown in Table 2, the lactic acid bacterium of Example 1 (Leuconostoc) was the lactic acid bacterium of Comparative Example 3 having the strongest fermentative power in less than half the time of the lactic acid bacterium of Comparative Example 4 (conventional Streptococcus salivarius). (Mesenteroides) can be fermented and coagulated in about half the time, which proves that it has a very strong fermenting power for soymilk.
Claims (4)
発酵された前記食品素材を飲食物に含有させる工程と、
を含む、発酵物を含有する飲食物を製造する方法。 Fermenting a food material with the lactic acid bacterium according to claim 1 ,
A step of including the fermented food material in food and drink,
A method for producing a food or drink containing a fermented product , comprising:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018196111A JP6651202B1 (en) | 2018-10-17 | 2018-10-17 | A novel lactic acid bacterium belonging to Streptococcus salivarius and its use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018196111A JP6651202B1 (en) | 2018-10-17 | 2018-10-17 | A novel lactic acid bacterium belonging to Streptococcus salivarius and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
JP6651202B1 true JP6651202B1 (en) | 2020-02-19 |
JP2020061977A JP2020061977A (en) | 2020-04-23 |
Family
ID=69568357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018196111A Active JP6651202B1 (en) | 2018-10-17 | 2018-10-17 | A novel lactic acid bacterium belonging to Streptococcus salivarius and its use |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6651202B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115093989A (en) * | 2022-04-08 | 2022-09-23 | 青岛农业大学 | A strain of Streptococcus salivarius QS-20 with antioxidant activity and its application |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7486728B2 (en) * | 2021-02-10 | 2024-05-20 | 株式会社インパクト | Lactic acid bacteria and foods and cosmetics that contain the same |
JP6921350B1 (en) * | 2021-02-25 | 2021-08-18 | 株式会社北岡本店 | New lactic acid bacteria belonging to Lactobacillus plantarum isolated from Yaezakura flowers and their utilization |
-
2018
- 2018-10-17 JP JP2018196111A patent/JP6651202B1/en active Active
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115093989A (en) * | 2022-04-08 | 2022-09-23 | 青岛农业大学 | A strain of Streptococcus salivarius QS-20 with antioxidant activity and its application |
Also Published As
Publication number | Publication date |
---|---|
JP2020061977A (en) | 2020-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101836862B1 (en) | Novel lactobacillus classified as lactobacillus plantarum, and use thereof | |
KR102028744B1 (en) | Lactobacillus plantarum HY7717 strain having immune-enhancing activity, antioxidative activity and digestive fluid resistance and use thereof | |
JP4746615B2 (en) | Bifidobacterium-containing fermented food and method for producing the same | |
TWI563923B (en) | Ricebecue powder extract composition | |
JP5598943B1 (en) | Composition for growing lactic acid bacteria | |
KR20150041519A (en) | latic acid bacteria fruit fermented liquor, latic acid bacteria fermentation fruit beverage and manufacturing method thereof | |
JP5011543B2 (en) | Method for producing fermented material containing GABA | |
JP4346559B2 (en) | Fermented beverage and its production method | |
JP6651202B1 (en) | A novel lactic acid bacterium belonging to Streptococcus salivarius and its use | |
US9750776B2 (en) | Agents for promoting secretion and/or suppressing decrease of adiponectin | |
JP6635479B1 (en) | A novel lactic acid bacterium belonging to Enterococcus faecium and its use | |
JP2009195251A (en) | Fermented beverage and method for preparation of the same | |
JP6921350B1 (en) | New lactic acid bacteria belonging to Lactobacillus plantarum isolated from Yaezakura flowers and their utilization | |
KR101014872B1 (en) | Food poisoning prevention and treatment composition containing soybean fermented product fermented with complex Kimchi lactic acid bacteria as an active ingredient | |
JP5413819B2 (en) | Liver function improving agent and its production tool, and use thereof | |
JP7444368B1 (en) | New lactic acid bacteria belonging to Lactiplantibacillus plantarum isolated from tulip flowers and their use | |
JP7578346B1 (en) | Three new lactic acid bacteria belonging to Lactiplantibacillus plantarum isolated from plum fruit, wisteria flower and persimmon fruit and their utilization | |
JP7035283B1 (en) | A novel lactic acid bacterium strain and a composition containing the novel lactic acid bacterium strain. | |
JP2017143799A (en) | Fermented milk food and drink | |
KR20230102580A (en) | Preparing method for soymilk yogurt using Bacillus subtilis | |
JP2019062803A (en) | Composition comprising novel lactic acid bacteria and novel lactic acid bacteria | |
AU2015200625A1 (en) | Agents for promoting secretion and/or suppressing decrease of adiponectin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190826 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20190830 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20190911 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191008 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191015 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191112 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191203 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20191217 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200114 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6651202 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |